Montana Mesothelioma Fact Sheet
While mesothelioma is a problem in all states, the specific incident rate for Montana is 1.4 / 100,000. This is above the average rate of 1.1 / 100,000. Click on the tabs below to find mesothelioma and asbestos research in MT, recent MT mesothelioma-related court cases, mesothelioma specialists in MT and potential asbestos hotspots in Montana.
Montana Mesothelioma Info
By clicking on the above tabs, you will find information on mesothelioma specific to the state of Montana
Montana Research and Clinical Trials
This is a partial list of scientific or medical grants in your state for research into mesothelioma and related illnesses.
Montana Doctors and Hospitals
This is a partial list of hospitals and physicians that reportedly treat mesothelioma patients in your state.
Montana Cases
This is a partial list of relevant court cases on mesothelioma in your state.
Disclaimer: Inclusion on this directory does not constitute endorsement by Cancer Monthly, Inc. All physicians who appear in this section do so based on their own expression of interest in the fields of mesothelioma treatment. Cancer Monthly, Inc. has not verified the competence, professional credentials, business practices or validity of the expressed interests of these physicians. Cancer Monthly makes no recommendation of any physician on this list and makes no suggestion that any such physician will cure or prevent any disease. Those consulting a physician on this list should approach the consultation exactly as they would with any other unknown physician.
This is a partial list of scientific or medical grants in your state for research into mesothelioma and related illnesses.
Montana Doctors and Hospitals
This is a partial list of hospitals and physicians that reportedly treat mesothelioma patients in your state.
Montana Cases
This is a partial list of relevant court cases on mesothelioma in your state.
Disclaimer: Inclusion on this directory does not constitute endorsement by Cancer Monthly, Inc. All physicians who appear in this section do so based on their own expression of interest in the fields of mesothelioma treatment. Cancer Monthly, Inc. has not verified the competence, professional credentials, business practices or validity of the expressed interests of these physicians. Cancer Monthly makes no recommendation of any physician on this list and makes no suggestion that any such physician will cure or prevent any disease. Those consulting a physician on this list should approach the consultation exactly as they would with any other unknown physician.
Orr v. State
No. 02-693 , SUPREME COURT OF MONTANA, June 26, 2003, Argued; November 12, 2003, Submitted , December 14, 2004, Decided
No. 02-693 , SUPREME COURT OF MONTANA, June 26, 2003, Argued; November 12, 2003, Submitted , December 14, 2004, Decided
Hospitals and Cancer Centers
We do not have any doctors or cancer centers for this state at the moment.
We do not have any doctors or cancer centers for this state at the moment.
| City | Site |
| Billings |
Carter Oil Refinery Conoco Refinery Yellowtail Dam |
| Columbia Falls |
Arco Aluminum Plant |
| Great Falls |
Catholic Hospital Minute Man Missile Site |
| Hardin |
Yellowtail Dam |
| Libby |
WR Grace |
Research
Pershouse, Mark A. Mt Cobre: Effect Of Metal Mixtures On Gene Expression & Carcinogenesis
Grant: 5P20RR017670-058036
Grant: 5P20RR017670-058036
Abstract: This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Mesotheliomas are tumors that form in the mesothelial lining of the peritoneal, pleural or pericardial cavities. There is a strong tie to asbestos exposure, with tumors arising in 10% exposed workers and a history of asbestos exposure in about 70% to 80% of all patients with mesothelioma. Tumors form through poorly understood mechanisms involving a small number of genetic lesions, allowing escape from normal cellular growth control. Published reports strongly implicate a small set of tumor suppressor genes or oncogenes involved in regulating normal cellular growth: specifically the retinoblastoma (Rb) gene, the p53 gene, p16 and p14/ARF genes, and the neurofibromatosis 2 gene (NF2). NF2 and p16/p14ARF are consistently inactivated by mutations in the DNA, while p53 and RB suffer few mutations, but are inactivated by other mechanisms. In addition, a transforming DNA tumor virus, SV40, is thought to play a role in tumor formation. We hope to better understand the role of two of these genes in inactivating p53: SV40 Large T antigen (Tag), and NF2. Our hypothesis is that both genes effectively target the p53 gene for inactivation. Our study design involves creation of in vitro and in vivo models of tumor formation. These models involve either the induction of SV40 Tag expression in normal mouse lung via a viral delivery system or the study of asbestos-induced tumor formation in NF2 knockout mice. We will readout the results of these genetic changes by cellular transformation assays in in vitro models or tumor incidence in animal models.
Tags: There Are No Thesaurus Terms On File For This Project.
Tags: There Are No Thesaurus Terms On File For This Project.
Clinical Trials
Condition: Malignant Mesothelioma
Intervention: Drug: pazopanib hydrochloride; Other: laboratory biomarker analysis
More Information
Intervention: Drug: pazopanib hydrochloride; Other: laboratory biomarker analysis
More Information
Condition: Malignant Mesothelioma
Intervention: Drug: cisplatin; Drug: gemcitabine hydrochloride
More Information
Intervention: Drug: cisplatin; Drug: gemcitabine hydrochloride
More Information
Have questions about mesothelioma?
If you want answers right now call our Mesothelioma Resource Specialist - Abby Palmer, MSW.
She takes calls throughout the day and early evening. Her number is: 619-261-7922.
She is not a doctor and does not provide medical advice.
DISCLAIMER: Surviving Mesothelioma® is registered with the United States Patent and Trademark Office by Cancer Monthly, Inc. and the website is owned and managed by Cancer Monthly Inc. All of the information provided on this website is for informational purposes only. Neither Cancer Monthly nor this website renders medical advice or professional services. The information provided by Abby Palmer or any other employee or contractor of Cancer Monthly, Inc. is not to be considered medical advice and is not intended to replace consultation with a qualified medical professional. You should consult a qualified health care provider for medical advice and answers to personal health questions. The responsibility of your disease management plan is with your treating physicians and you should only follow your treating physician’s advice. DO NOT change or modify your disease management plan on your own without consulting your treating physicians. This website is not a substitute for professional medical advice, examination, diagnosis or treatment. This website should not be used for diagnosing or treating a health problem or disease and it is not a substitute for professional care. You should always seek the advice of your physician or other qualified health professional before starting any new treatment or making any changes to an existing treatment. You should not delay in seeking or disregard medical advice based on information on this website. Some information may be out of date. The information on this website is intended to convey general information only. It should not be construed as legal advice or opinion. This website and its contents are not intended to create an attorney-client relationship. You should not act on or rely on any information on this website without seeking the advice of an attorney. You are encouraged to promptly speak to legal counsel to identify and protect your legal rights and any deadlines for filing a claim or lawsuit. People who request a free book may be called to verify their address and to introduce other mesothelioma resources that are available.